
pmid: 23177287
NS5A protein plays a key role in hepatitis C virus (HCV) replication. Daclatasvir (DCV, BMS-790052) is a first-in-class inhibitor of the HCV NS5A replication complex with potent antiviral activity but a low barrier to resistance. DCV as triple therapy in combination with pegylated interferon and ribavirin resulted in a high rate of early virologic response in treatment-naïve patients with genotype 1 infection; as quadruple therapy in combination with asunaprevir (BMS-650032, NS3 protease inhibitor), pegylated interferon, and ribavirin, it resulted in a high rate of sustained virologic response in genotype 1 prior null responders.
Sulfonamides, Pyrrolidines, Interleukins, Imidazoles, Interferon-alpha, Valine, Hepacivirus, Interferon alpha-2, Viral Nonstructural Proteins, Isoquinolines, Antiviral Agents, Hepatitis C, Recombinant Proteins, Polyethylene Glycols, Ribavirin, Humans, Drug Therapy, Combination, Protease Inhibitors, Carbamates, Interferons
Sulfonamides, Pyrrolidines, Interleukins, Imidazoles, Interferon-alpha, Valine, Hepacivirus, Interferon alpha-2, Viral Nonstructural Proteins, Isoquinolines, Antiviral Agents, Hepatitis C, Recombinant Proteins, Polyethylene Glycols, Ribavirin, Humans, Drug Therapy, Combination, Protease Inhibitors, Carbamates, Interferons
| selected citations These citations are derived from selected sources. This is an alternative to the "Influence" indicator, which also reflects the overall/total impact of an article in the research community at large, based on the underlying citation network (diachronically). | 40 | |
| popularity This indicator reflects the "current" impact/attention (the "hype") of an article in the research community at large, based on the underlying citation network. | Top 10% | |
| influence This indicator reflects the overall/total impact of an article in the research community at large, based on the underlying citation network (diachronically). | Top 10% | |
| impulse This indicator reflects the initial momentum of an article directly after its publication, based on the underlying citation network. | Top 10% |
